Omalizumab (Xolair) Lyophilized Powder from Germany
Omalizumab is a humanized monoclonal antibody binding IgE for severe asthma treatment. It fits HTS 3002.15.00.11 as a biotech immunological product in measured doses for retail sale.
Duty Rate — Germany → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Validate IgE specificity; declare asthma prophylactic immunological use